| Literature DB >> 35757248 |
Bi Luo1,2,3, Jia Lv1,2,3, Kejie Li1,2,3, Peiran Liao1,2,3, Peng Chen4.
Abstract
This study aimed to extract polysaccharides from Citrus medica L. var. sarcodactylis (finger citron fruits) and analyze their structures and potential bioactivities. A new polysaccharide named K-CMLP was isolated and purified by Diethylaminoethylcellulose (DEAE)-Sepharose Fast Flow and DEAE-52 cellulose column chromatography with an average molecular weight of 3.76 × 103 kDa. Monosaccharide composition analysis revealed that K-CLMP consisted of rhamnose, galactose, and glucose, with a molar ratio of 6.75:5.87:1.00. Co-resolved by methylation and two-dimensional nuclear magnetic resonance (NMR), K-CLMP was alternately connected with 1, 2-Rha and 1, 4-Gal to form the backbone, and a small number of glucose residues was connected to O-4 of rhamnose. The results of DPPH⋅ and ABTS+⋅ radical scavenging assays indicated that both crude polysaccharide Citrus medica L. var. polysaccharide (CMLP) and K-CLMP exhibited strong free-radical-scavenging properties in a dose-dependent manner. In addition, K-CMLP significantly inhibited the production of pro-inflammatory cytokines (IL-6 and TNF-α) and reactive oxygen species (ROS) in RAW 264.7 cells treated with LPS. These results provide a basis for further use as one of the potential functions of food or natural medicine.Entities:
Keywords: Citrus medica L. var. sarcodactylis; anti-inflammatory activity; antioxidant activity; galactorhamnan polysaccharide; structure characterization
Year: 2022 PMID: 35757248 PMCID: PMC9225144 DOI: 10.3389/fnut.2022.916976
Source DB: PubMed Journal: Front Nutr ISSN: 2296-861X
FIGURE 1DEAE cellulose-52 fractionation profile of polysaccharide K-CMLP.
FIGURE 2High-performance gel-permeation chromatography chromatogram of polysaccharide K-CMLP.
Composition analysis of bergamot polysaccharide.
| Item | CMLP | K-CMLP |
| Carbohydrate (%) | 96.35 ± 4.23 | 98.36 ± 2.35 |
| Protein (%) | – | 0.14 ± 0.06 |
| Uronic acid (%) | 3.03 ± 0.35 | 1.57 ± 0.45 |
| Monosaccharide | ||
| Glc | 15.64 | 7.39 |
| Rha | 27.54 | 43.38 |
| Ara | 8.3 | – |
| Gal | 39.73 | 49.88 |
| Gal A | 8.79 | – |
FIGURE 3High-performance liquid chromatography pre-column PMP derivative chromatogram of mixed monosaccharide standard, CMLP, and K-CMLP.
Methylation analysis of restored K-CMLP.
| Methylation sugar | Ratio | Linkage type | Mass fragments (m/z) |
| 3, 4-Me2-Rha | 3.9 | 1, 2-Rha | 43,57,59,72,88,89,100,115,130,131,160,174,190 |
| 3-Me-Rha | 1.0 | 1, 2,4-Rha | 43,59,69,74,88,101,130,143,160,171,190,203 |
| 2, 3, 6-Me3-Gal | 4.8 | 1, 4-Gal | 43,59,71,87,99,102,113,118,129,131,142,162,173,188,203,233 |
| 2, 3, 4, 6-Me4-Glc | 1.1 | T-Glc | 43,59,71,75,87,88,101,102,113,118,129,145,161,162,175,205 |
FIGURE 4The total ion chromatogram of K-CMLP by GC-MS.
FIGURE 5The NMR spectroscopy of polysaccharide K-CMLP. 1H NMR (A), 13C NMR (B), 1H- 1H COSY (C), 1H-13C HSQC (D), and 1H-13C HMBC (E).
Chemical shift assignment of K-CMLP.
| Code | 1H/13C NMR δ [ppm] | |||||
|
| ||||||
| 1 | 2 | 3 | 4 | 5 | 6 | |
| Gal | 4.38 | 3.30 | 3.58 | 3.62 | 3.75 | 3.73 |
| 101.1 | 72.5 | 75.8 | 66.4 | 69.3 | 60.1 | |
| Rha | 5.32 | 4.07 | 3.68 | – | 3.63 | 1.18 |
| 98.5 | 77.6 | 76.5 | – | 72.4 | 18.4 | |
| Glc | 5.21 | 3.97 | – | – | – | – |
| 96.1 | – | – | – | – | – | |
(–) Polysaccharide resonances were not assigned due to low intensity and overlap with other resonances.
FIGURE 6Schematic diagram of polysaccharide K-CMLP.
FIGURE 7Antioxidant activities of CMLP and K-CMLP: DPPH⋅ radical-scavenging activity (A); ABTS+⋅ radical-scavenging activity (B). Values are the mean ± SD of three replicates.
FIGURE 8Cytotoxicity of K-CMLP in RAW 264.7 macrophages at the different concentration (10, 100, 200, 400 μg/mL).
FIGURE 9Anti-inflammation effect of K-CMLP on production of pro-inflammatory cytokines [TNF-α (A), IL-6 (B)], cell counts (C) and reactive oxygen species (ROS) scavenging activity (D) in LPS induced RAW 264.7 cells model. Values represent the mean ± SE (bars) from eight independent samples (n = 3). * Means P < 0.05, ** means P < 0.05, ***P < 0.0005, and ****P < 0.0001 compared with the only LPS treated group for incubating 24 h.